Statogen Consulting is a biostatistics consulting company specializing in advanced pharmaceutical design and analysis of nonclinical and clinical trials, to assist the biotechnology, pharmaceutical and medical device industries in bringing new products to market. We assist throughout the entire product cycle, from nonclinical to first-in-man dose-finding studies (phase I), efficacy studies (phase II), effectiveness and comparative trials (phase III) through submission.

We have had plenty of experience applying principles of adaptive study design, a methodology in which we evaluate trial results continually beginning in early stages, and modify study design parameters as required.

Our goal to ensure that basic scientific discoveries translate more rapidly into new and better medical treatments by creating new tools and methods to find answers about how the safety and effectiveness of new medical products demonstrate in faster time-frames with more certainty, at lower costs, and with better information.